Loss-of-function variations in the SLC29A3 gene underlie a group of histiocytic diseases collectively referred to as SLC29A3 disorders, characterized by histiocytosis, hepatosplenomegaly, skin pigmentation, hypertrichosis and type I diabetes (Fig. 2) (2,  19). This evidence concerns the gene SLC29A3 and hypertrichosis.